Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Patients
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2016
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Roche
- 08 Dec 2008 Status changed from active, no longer recruiting to completed.
- 23 Jun 2006 New trial record.